2/9
12:27 pm
sldb
Solid Biosciences (NASDAQ:SLDB) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
Low
Report
Solid Biosciences (NASDAQ:SLDB) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
2/9
11:51 am
sldb
Rating for SLDB
Low
Report
Rating for SLDB
2/9
11:51 am
sldb
Rating for SLDB
Low
Report
Rating for SLDB
1/14
12:30 pm
sldb
Solid Biosciences (NASDAQ:SLDB) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
Low
Report
Solid Biosciences (NASDAQ:SLDB) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
1/14
12:24 pm
sldb
Rating for SLDB
Low
Report
Rating for SLDB
1/14
12:24 pm
sldb
Rating for SLDB
Low
Report
Rating for SLDB
12/17
08:45 am
sldb
Solid Biosciences (NASDAQ:SLDB) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
High
Report
Solid Biosciences (NASDAQ:SLDB) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
12/6
05:47 am
sldb
Solid Biosciences (NASDAQ:SLDB) was upgraded by analysts at Needham & Company LLC to a "moderate buy" rating.
Low
Report
Solid Biosciences (NASDAQ:SLDB) was upgraded by analysts at Needham & Company LLC to a "moderate buy" rating.